Zantac Users Pile On Cancer Claims Ahead Of JPML Hearing
Sanofi was hit with another proposed class action by a woman in Chicago who alleges the drugmaker failed to warn consumers that Zantac contained a potent carcinogen, a week before a...To view the full article, register now.
Already a subscriber? Click here to view full article